Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Grieve

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Diabetes|July 29, 2003
Vascular endothelial function and blood pressure homeostasis in mice overexpressing IGF binding protein-1Stephen B Wheatcroft, Mark T Kearney, Ajay M Shah, et al.
Cardiovascular Drugs and Therapy|July 10, 2026
DNA/RNA Methylation-Driven Coronary Microvascular Dysfunction: Emerging Pathogenic Mechanisms and Therapeutic Opportunities for Heart Failure in DiabetesAriana Bacelar-Jimenez, Ammar S Alamareen, Vinuthna Vani Madishetti, et al.
Cancer Research|October 2, 2010
Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapyYouyou Zhao, Declan McLaughlin, Emma Robinson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 28, 2005
Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin IJoanne Layland, Alison C Cave, Chad Warren, et al.
British Journal of Pharmacology|March 7, 2017
Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2Declan McLaughlin, Youyou Zhao, Karla M O'Neill, et al.
Circulation Research|October 11, 2003
Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophyJonathan A Byrne, David J Grieve, Jennifer K Bendall, et al.
Hypertension (Dallas, Tex. : 1979)|January 9, 2008
Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarctionYee H Looi, David J Grieve, Anjana Siva, et al.
Journal of Cell Science|July 24, 2019
The RNA-binding protein QKI controls alternative splicing in vascular cells, producing an effective model for therapyRachel Caines, Amy Cochrane, Sophia Kelaini, et al.
Cardiovascular Diabetology|April 16, 2016
Metabolically-inactive glucagon-like peptide-1(9-36)amide confers selective protective actions against post-myocardial infarction remodellingEmma Robinson, Mitchel Tate, Samuel Lockhart, et al.
Oxidative Medicine and Cellular Longevity|February 12, 2021
GSTM1 Modulates Expression of Endothelial Adhesion Molecules in Uremic MilieuDjurdja Jerotic, Sonja Suvakov, Marija Matic, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Diabetes|July 29, 2003
Vascular endothelial function and blood pressure homeostasis in mice overexpressing IGF binding protein-1Stephen B Wheatcroft, Mark T Kearney, Ajay M Shah, et al.
Cardiovascular Drugs and Therapy|July 10, 2026
DNA/RNA Methylation-Driven Coronary Microvascular Dysfunction: Emerging Pathogenic Mechanisms and Therapeutic Opportunities for Heart Failure in DiabetesAriana Bacelar-Jimenez, Ammar S Alamareen, Vinuthna Vani Madishetti, et al.
Cancer Research|October 2, 2010
Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapyYouyou Zhao, Declan McLaughlin, Emma Robinson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 28, 2005
Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin IJoanne Layland, Alison C Cave, Chad Warren, et al.
British Journal of Pharmacology|March 7, 2017
Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2Declan McLaughlin, Youyou Zhao, Karla M O'Neill, et al.
Circulation Research|October 11, 2003
Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophyJonathan A Byrne, David J Grieve, Jennifer K Bendall, et al.
Hypertension (Dallas, Tex. : 1979)|January 9, 2008
Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarctionYee H Looi, David J Grieve, Anjana Siva, et al.
Journal of Cell Science|July 24, 2019
The RNA-binding protein QKI controls alternative splicing in vascular cells, producing an effective model for therapyRachel Caines, Amy Cochrane, Sophia Kelaini, et al.
Cardiovascular Diabetology|April 16, 2016
Metabolically-inactive glucagon-like peptide-1(9-36)amide confers selective protective actions against post-myocardial infarction remodellingEmma Robinson, Mitchel Tate, Samuel Lockhart, et al.
Oxidative Medicine and Cellular Longevity|February 12, 2021
GSTM1 Modulates Expression of Endothelial Adhesion Molecules in Uremic MilieuDjurdja Jerotic, Sonja Suvakov, Marija Matic, et al.
Pageof 7